Robinhood: Here's why Needham upgraded the stock to buy
John Todaro, analyst at Needham, joins CNBC's 'Money Movers' to discuss why his firm is upgrading Robinhood to a buy, what ...
Needham downgrades Biogen on slow growth of Alzheimer's drug
Investing.com - Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's ...
Joby and Archer Aviation shares soar after new Buy ratings but patience key for those stocking up
Joby and Archer stocks surged after Needham's Buy ratings and forecasts. Learn why investors may need patience for these ...
Joby Aviation initiated with a Buy at Needham
Needham initiated coverage of Joby Aviation (JOBY) with a Buy rating and $8 price target. The firm sees Joby as best positioned to win early ...
17-year-old Needham girl killed in Vermont crash
A 17-year-old girl from Massachusetts died in a crash in Shrewsbury, Vermont, on Sunday, officials say. At 4:06 a.m., ...
Coinbase price target raised to $375 from $290 at Needham
Needham analyst John Todaro raised the firm’s price target on Coinbase (COIN) to $375 from $290 and keeps a Buy rating on the shares. The firm ...
Sale closed in Needham Heights: $2.2 million for a five-bedroom home
A spacious historic house located at 113 Hunnewell Street in Needham Heights has a new owner. The 3,907-square-foot property, ...
Why Joby Aviation Stock Soared Today
Joby's valuation climbed today after Needham initiated coverage on the stock with a buy rating and a one-year price target of $8 per share. Even after today's gains, the firm's price target suggests ...
SharkNinja to Participate in the Morgan Stanley Global Consumer & Retail Conference
SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced that the Company will be participating in the Morgan Stanley Global Consumer & Retail Conference in New ...
Needham认为SI-BONE股票近期疲软提供买入机会
SI-BONE的财务健康被强调为维持买入评级的关键因素。公司强健的资产负债表被视为一个重要的积极方面，为潜在的罚款提供了缓冲，并支持调查后的复苏前景。这种财务稳定性是Needham在当前市场波动中建议买入SI-BONE股票的基石。
Needham维持Medtronic评级为"持有"，此前公司公布第二季度业绩
周二，Needham重申了对美敦力公司(Medtronic, Inc.)(NYSE:MDT)的"持有"评级，此前这家医疗技术公司公布了2025财年第二季度财务业绩。该机构未设定新的目标价。美敦力第二季度的收入和每股收益(EPS)均超过了市场预期，促使管理层小幅上调了2025财年全年的收入和EPS指引。 美敦力的有机增长略有放缓，2025财年第二季度增长5.0%，相比第一季度的5.3%有所下降。这一 ...